to beta-lactam antibiotics
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Dec 25, 2012
Grant Date -
Feb 11, 2010
app pub date -
Dec 29, 2005
filing date -
Dec 29, 2005
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
Contemplated methods and compositions further increase susceptibility of sensitized MRSA against various antibiotic drugs. Most preferably, the MRSA is already sensitized with a galloylated catechin (e.g., ECG), and further sensitization is achieved by exposure to a non-galloylated catechin (e.g., EC), and most preferably the corresponding non-galloylated catechin.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully